Target intelligence / Profile preview

Satiety regulation via gut fiber effects

Molecular classification
Other
01

Overview

This entry refers to the *mechanism* by which dietary fiber modulates satiety, not a single molecular target. Dietary fiber, especially fermentable types, is metabolized by gut microbes to produce short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate. These SCFAs act on free fatty acid receptors (FFAR2/GPR43 and FFAR3/GPR41) on enteroendocrine L cells, stimulating the secretion of satiety hormones like glucagon-like peptide 1 (GLP-1) and peptide YY (PYY). These hormones, as well as cholecystokinin (CCK), transmit signals to the brain either through the circulation or the vagal nerve, delaying gastric emptying, reducing hunger, and ultimately lowering food intake. Thus, \"satiety regulation via gut fiber effects\" is a broad mechanism, using multiple molecular and neural routes to promote feelings of fullness and regulate energy balance[1][2][3]. This is not considered a single therapeutic target; it is a physiological mechanism involving diverse receptors and signaling pathways. For structured database purposes, research should instead focus on specific contributing molecules such as \"Glucagon-like peptide 1 receptor,\" \"Peptide YY receptor Y2,\" or \"Free fatty acid receptor 2 (GPR43)\" when molecular-level detail is required[1][2].

Other names
fiber-induced satietydietary fiber-induced appetite regulationgut microbiota-mediated satiety
02

Mechanism of action

Stimulation of enteroendocrine cells to release satiety hormones (GLP-1, PYY, CCK); Fermentation by gut microbes to generate SCFAs, which activate receptors (e.g., FFAR2, FFAR3); Modulation of gut-brain neural circuits via vagal nerve activation

03

Biological functions

Appetite regulationEnergy homeostasisGut-brain signalingHormone secretion
04

Disease associations

ObesityMetabolic syndromeDiabetesOther (weight management disorders)
05

Safety considerations

Excessive fiber can cause gastrointestinal discomfort, bloating, or altered microbiota profiles in sensitive individuals[1]
06

Interacting drugs

Not applicable for a mechanism; certain fiber supplements and probiotics may modulate these pathways, but no direct drugs \"bind\" this effect[1][2][3].
07

Biomarkers

Plasma levels of GLP-1, PYY, CCKSCFA concentrations in blood or feces

Beyond the preview

Go deeper on Satiety regulation via gut fiber effects.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Satiety regulation via gut fiber effects.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call